neoplasm
• the hepatocarcinogenesis observed in diethylnitrosamine (DEN) treated single Tg(Myl2-FGF19)1Dfre mutants is abolished in double mutants
|
• mutants do not develop gross or histological evidence of hepatocellular neoplasia unlike single Tg(Myl2-FGF19)1Dfre mutant mice which develop hepatocellular carcinoma
• the preneoplastic hepatocellular proliferation that is seen in single Tg(Myl2-FGF19)1Dfre mutants is not evident in double mutants
|
homeostasis/metabolism
• the hepatocarcinogenesis observed in diethylnitrosamine (DEN) treated single Tg(Myl2-FGF19)1Dfre mutants is abolished in double mutants
|
liver/biliary system
• mutants do not develop gross or histological evidence of hepatocellular neoplasia unlike single Tg(Myl2-FGF19)1Dfre mutant mice which develop hepatocellular carcinoma
• the preneoplastic hepatocellular proliferation that is seen in single Tg(Myl2-FGF19)1Dfre mutants is not evident in double mutants
|